168 results on '"Bansal, Shyam S."'
Search Results
2. Ion Channels in Immune Cells
3. Introduction
4. Helper T-Lymphocytes in Cardiovascular Diseases
5. Immune Cells, Inflammation, and Cardiovascular Diseases
6. Guidelines on antibody use in physiology research
7. Early Inflammation in Muscular Dystrophy Differs between Limb and Respiratory Muscles and Increases with Dystrophic Severity
8. Fibroblast growth factor-inducible 14 mediates macrophage infiltration in heart to promote pressure overload-induced cardiac dysfunction
9. Cardiovascular inflammation: RNA takes the lead
10. Guidelines on antibody use in physiology research.
11. Abstract P3093: Early Myocarditis In The Desmoglein 2 Mutant Mouse Model Of Arrhythmogenic Cardiomyopathy
12. Nanospheres
13. CCR2+ Monocyte-Derived Infiltrating Macrophages Are Required for Adverse Cardiac Remodeling During Pressure Overload
14. Data from Curcumin Implants, Not Curcumin Diet, Inhibit Estrogen-Induced Mammary Carcinogenesis in ACI Rats
15. Supplementary Figure Legends from Curcumin Implants, Not Curcumin Diet, Inhibit Estrogen-Induced Mammary Carcinogenesis in ACI Rats
16. Supplementary Figures 1 - 3 from Curcumin Implants, Not Curcumin Diet, Inhibit Estrogen-Induced Mammary Carcinogenesis in ACI Rats
17. Response by Bansal et al to Letter Regarding Article, “Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy”
18. Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy
19. CLIC4 localizes to mitochondrial-associated membranes and mediates cardioprotection
20. Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy
21. CD4+ T-lymphocytes exhibit biphasic kinetics post-myocardial infarction
22. Abstract P3068: TNFR1 Regulates Cellular Proliferation And Not Pathogenicity Of Cd4 + T-lymphocytes During Ischemic Heart Failure
23. Antifungal Activity of Medicinal Plant Extracts and Phytocompounds: A Review
24. Abstract 18758: Dysfunctional Regulatory T-lymphocytes are Pro-inflammatory and Anti-angiogenic in Heart Failure: A Role for TNF-TNFR1 Signaling
25. Estrogen Receptor-β Agonists Modulate T-Lymphocyte Activation and Ameliorate Left Ventricular Remodeling During Chronic Heart Failure
26. Editorial: Targeting Dysregulated Inflammation to Treat Cardiovascular Diseases
27. Cucurbitacin B potently suppresses non-small-cell lung cancer growth: Identification of intracellular thiols as critical targets
28. Activated T Lymphocytes are Essential Drivers of Pathological Remodeling in Ischemic Heart Failure
29. Multi-layer polymeric implants for sustained release of chemopreventives
30. Controlled systemic delivery by polymeric implants enhances tissue and plasma curcumin levels compared with oral administration
31. Myeloid mineralocorticoid receptors contribute to skeletal muscle repair in muscular dystrophy and acute muscle injury
32. BEX1 is a critical determinant of viral myocarditis
33. Leukocyte iNOS is required for inflammation and pathological remodeling in ischemic heart failure
34. TNFR1 Contributes to Activation Induced Cell Death of Pathological Cd4+ T-Lymphocytes During Ischemic Heart Failure
35. Abstract MP229: Signaling Mechanisms Leading To CD4+ T-lymphocyte Activation During Ischemic Heart Failure
36. Estrogenic bias in T-Lymphocyte biology: Implications for cardiovascular disease
37. Mild Hyperthermia Enhances Transport of Liposomal Gemcitabine and Improves In Vivo Therapeutic Response
38. Characterization of nanochannel delivery membrane systems for the sustained release of resveratrol and atorvastatin: new perspectives on promoting heart health
39. Nanospheres
40. Curcumin implants for continuous systemic delivery: safety and biocompatibility
41. Development and In Vitro-In Vivo Evaluation of Polymeric Implants for Continuous Systemic Delivery of Curcumin
42. Optimized Protocols for Isolation, Fixation and Flow Cytometric Characterization of Leukocytes in Ischemic Hearts
43. Immune cell dilemma in ischemic cardiomyopathy: to heal or not to heal
44. New Dosage Formulations for Targeted Delivery of Cyclo-Oxygenase-2 Inhibitors: Focus on Use in the Elderly
45. Silicon Micro- and Nanofabrication for Medicine
46. Controlled-release systemic delivery - a new concept in cancer chemoprevention
47. Abstract 101: Novel Inhibitors for Temporal Modulation of T-lymphocytes During Chronic Heart Failure
48. Abstract 429: Tnf Receptor-1 Dictates Life/death Decisions of Auto-reactive T-lymphocytes During Heart Failure
49. The Apolipoprotein A-I Mimetic L-4F Attenuates Monocyte Activation and Adverse Cardiac Remodeling after Myocardial Infarction
50. Optimized protocols for isolation, fixation, and flow cytometric characterization of leukocytes in ischemic hearts
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.